FMP

FMP

Enter

KRBP - Kiromic BioPharma, I...

Financial Summary of Kiromic BioPharma, Inc.(KRBP), Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages

photo-url-https://financialmodelingprep.com/image-stock/KRBP.png

Kiromic BioPharma, Inc.

KRBP

NASDAQ

Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin; and ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy product candidate targeting PD-L1. It has license agreements with CGA 369 Intellectual Holdings, Inc. and Longwood University, as well as a research and development collaboration agreement with Molipharma, S.R.L. The company also has strategic alliance agreement with Leon Office (H.K.) Ltd. The company was formerly known as Kiromic, Inc. and changed its name to Kiromic BioPharma, Inc. in December 2019. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas.

2.51 USD

-0.09 (-3.59%)

About

ceo

Mr. Pietro Bersani CPA, J.D.

sector

Healthcare

industry

Biotechnology

website

https://www.kiromic.com

exchange

NASDAQ

Description

Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin; and ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy product candidate targeting PD-L1. It has license agreements with CGA 369 Intellectual Holdings, Inc. and Longwood University, as well as a research and development collaboration agreement with Molipharma, S.R.L. The company also has strategic alliance agreement ...

CIK

0001792581

ISIN

US4976342042

CUSIP

497634105

Address

7707 Fannin

Phone

832 968 4888

Country

US

Employee

35

IPO Date

Oct 16, 2020

Summary

CIK

0001792581

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

497634105

ISIN

US4976342042

Country

US

Price

2.51

Beta

2.04

Volume Avg.

3.4k

Market Cap

3.87M

Shares

-

52-Week

0.16-4.08

DCF

0

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.34

P/B

-

Website

https://www.kiromic.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest KRBP News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep